DNTH Dianthus Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 5, 2026 10-K/10-Q Ago 4, 2026
$88,04
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$32,22minimo 52 sett.
$117,88massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$4.82B
P/E
-21.0
EPS
$-4.20
Ricavi
$2M
i tuoi badge
Intervallo 52 sett.
$32–$118
Rating Analisti
BUY
Prezzo Obiettivo
$141
P/E
-21.0
ROE
-40.8%
Margine di Profitto Netto
-7973.3%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
DNTH Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$88.04
Capitalizzazione di Mercato (MRQ)
$4.82B
P/E
-21.0
EPS
$-4.20
Ricavi
$2M
ROE
-40.8%
Intervallo 52 sett.
$32–$118
DNTH Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Informazioni su Dianthus Therapeutics, Inc. - Common Stock Panoramica della società da Wikipedia
settoreHealthcare
industriaBiotechnology
dipendenti92
paeseUS
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$2M2016-12-31 → 2025-12-31
EPS$-4.202020-12-31 → 2025-12-31
Flusso di cassa libero·2018-12-31 → 2021-12-31
Margine netto-7973.3%2024-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | DNTH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -21.0media 5 anni ≈-14.9 | ≈-14.9 | · | · | |
| P/S | 1869.0media 5 anni ≈346.1 | ≈346.1 | 55.0 | Sopravvalutato | |
| P/B (MRQ) | 4.1media 5 anni ≈7.6 | ≈7.6 | 8.1 | Sottovalutato | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -29.5media 5 anni ≈-24.2 | ≈-24.2 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 7.7media 5 anni ≈2.1 | ≈2.1 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | DNTH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Operating Margin (Margine Operativo) | -8739.3% | · | -101.3% | Debole | |
| EBITDA Margin (Margine EBITDA) | -8739.3% | · | -101.3% | Debole | |
| Net Profit Margin (Margine di Profitto Netto) | -7973.3% | · | -100.5% | Debole | |
| ROA | -35.9%media 5 anni ≈-35.1% | ≈-35.1% | -28.1% | Debole | |
| ROE | -40.8%media 5 anni ≈-32.4% | ≈-32.4% | -41.5% | In linea |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | DNTH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 26.1media 5 anni ≈15.9 | ≈15.9 | 6.5 | Liquidità elevata | |
| Quick Ratio (MRQ) | 25.8media 5 anni ≈15.6 | ≈15.6 | 2.9 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | DNTH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | -67.3% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | DNTH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0 | · | 0.2 | Debole | |
| Receivables Turnover (Rotazione dei crediti) | 78.3 | · | 9.7 | Di prim'ordine | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$22.1K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-2.5%
Prossimo report
Nov 03, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 6, 2026 | $-0.90 | $-0.87 | -2.9% |
| 31 Marzo 2026 | Mag 11, 2026 | $-0.85 | $-1.09 | 22.3% |
| 31 Dicembre 2025 | $-1.43 | $-1.10 | -30.3% | |
| 30 Settembre 2025 | $-0.97 | $-0.88 | -10.3% | |
| 30 Giugno 2025 | $-0.88 | $-0.89 | 1.0% | |
| 31 Marzo 2025 | $-0.82 | $-0.87 | 5.3% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $6M | $3M | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $146M | $83M | $33M | $29M | $47M | $51M | $59M | $41M | $28M | |
| SG&A Expense | $34M | $25M | $18M | $7M | $28M | $28M | $24M | $19M | $8M | |
| Operating Expenses | $180M | $108M | $51M | $36M | $75M | $79M | $83M | $60M | $36M | |
| Operating Income | $-178M | $-102M | $-48M | $-30M | $-75M | $-79M | $-83M | $-60M | $-36M | |
| Interest Income | $16M | $17M | $5M | · | · | · | · | · | · | |
| Other Non-op | $-974.0K | $-554.0K | $-60.0K | $-52.0K | · | · | · | $2M | $236.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-162M | $-85M | $-44M | $-28M | $-71M | $-75M | $-77M | $-58M | $-35M | |
| EPS (Basic) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · | |
| EPS (Diluted) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · | |
| Shares (Basic) | 38,617,580 | 33,313,849 | 5,153,423 | 874,234 | 54,948,808 | 43,920,121 | · | · | · | |
| Shares (Diluted) | 38,617,580 | 33,313,849 | 5,153,423 | 874,234 | 54,948,808 | 43,920,121 | · | · | · | |
| EBITDA | $-178M | $-102M | $-48M | · | $-73M | $-77M | $-81M | $-59M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $23M | $132M | $15M | $132M | $58M | $65M | $58M | $51M | |
| Short-term Investments | $353M | $252M | $41M | $60M | $45M | $91M | $81M | $84M | · | |
| Receivables | $52.0K | $0 | $294.0K | $5M | · | · | · | · | · | |
| Prepaid Expense | $5M | $5M | $3M | $905.0K | $4M | $3M | $4M | $3M | $936.0K | |
| Other Current Assets | $86.0K | $355.0K | $0 | · | · | · | · | · | · | |
| Current Assets | $409M | $281M | $177M | $82M | $181M | $152M | $150M | $145M | $53M | |
| PP&E (Net) | $296.0K | $194.0K | $185.0K | $142.0K | $7M | $8M | $10M | $10M | $2M | |
| PP&E (Gross) | $600.0K | $387.0K | $282.0K | $172.0K | $14M | $13M | $13M | $11M | $2M | |
| Accum. Depreciation | $304.0K | $193.0K | $97.0K | $30.0K | $7M | $5M | $3M | $1M | $382.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | $4.0K | |
| Total Assets | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | |
| Accounts Payable | $10M | $5M | $3M | $1M | $3M | $4M | $3M | $3M | $167.0K | |
| Accrued Liabilities | $19M | $13M | $7M | $7M | $8M | $8M | $11M | $7M | $4M | |
| Current Liabilities | $31M | $18M | $10M | $8M | $11M | $11M | $14M | $10M | $4M | |
| Capital Leases | $1M | $1M | $168.0K | $438.0K | $0 | · | · | · | · | |
| Total Liabilities | $38M | $22M | $11M | $9M | $17M | $18M | $20M | $12M | $4M | |
| Common Stock | $43.0K | $31.0K | $15.0K | $0 | $59.0K | $49.0K | $39.0K | $33.0K | $2.0K | |
| Retained Earnings | $-337M | $-174M | $-89M | $-46M | $-326M | $-254M | $-179M | $-103M | $-45M | |
| AOCI | $489.0K | $106.0K | $47.0K | $-161.0K | $-30.0K | $-23.0K | $8.0K | $-8.0K | · | |
| Stockholders' Equity | $493M | $352M | $169M | $-44M | $-17M | $144M | $141M | $146M | $-42M | |
| Liabilities + Equity | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | |
| Shares Outstanding | 43,223,090 | 31,115,341 | 14,817,696 | 875,279 | 58,799,157 | 48,533,135 | 39,260,532 | 33,305,033 | 2,351,247 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $875.0K | $376.0K | |
| Stock-based Comp | $23M | $13M | $3M | $2M | $10M | $10M | $10M | $11M | $2M | |
| Other Non-cash | · | · | · | · | $-723.0K | $-1M | $8M | $4M | · | |
| Operating Cash Flow | $-129M | $-78M | $-37M | $-29M | $-60M | $-64M | $-57M | $-42M | $-22M | |
| CapEx | · | · | · | $314.0K | $1M | $400.0K | $3M | $8M | $2M | |
| Investing Cash Flow | $-123M | $-287M | $20M | $-60M | $43M | $-11M | $2M | $-92M | $-2M | |
| Stock Issued | $317.0K | $0 | $0 | $3M | $0 | $65M | $61M | $93M | · | |
| Net Stock Activity | $317.0K | $39M | · | · | · | $65M | $61M | · | · | |
| Financing Cash Flow | $280M | $256M | $134M | $97M | $90M | $68M | $62M | $142M | $71M | |
| Net Change in Cash | $28M | $-109M | $117M | $8M | $73M | $-7M | $7M | $9M | $47M | |
| Taxes Paid | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | $-61M | $-64M | $-60M | $-50M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8739.3% | -1633.7% | · | · | · | · | · | · | · | |
| Net Margin | -7973.3% | -1362.8% | · | · | · | · | · | · | · | |
| EBITDA Margin | -8739.3% | -1633.7% | · | · | · | · | · | · | · | |
| ROA | -35.9% | -30.7% | -33.2% | · | -40.5% | -46.4% | -48.2% | -54.3% | · | |
| ROE | -40.8% | -24.6% | -25.1% | · | -39.3% | -49.5% | -50.7% | -37.7% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.3 | 15.2 | 18.4 | · | 16.6 | 13.3 | 10.6 | 13.9 | · | |
| Quick Ratio | 13.2 | 15.0 | 18.1 | · | 16.3 | 13.0 | 10.3 | 13.7 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | 0.0 | 0.0 | · | |
| Receivables Turnover | 78.3 | 11.3 | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $11.42 | $11.33 | $11.40 | · | $2.94 | $2.97 | $3.60 | $4.37 | · | |
| Revenue / Share | $0.05 | $0.19 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-3.34 | $-2.35 | $-7.15 | · | $-1.08 | · | · | · | · | |
| Cash / Share | $1.18 | $0.73 | $8.93 | · | $2.24 | $1.20 | $1.66 | $1.75 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | |
| EPS (TTM) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -67.3% | 120.6% | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $6M | $3M | · | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-162M | $-85M | $-44M | $-28M | $-71M | $-75M | $-77M | $-58M | · | |
| Market Cap | $1.78B | $678M | $154M | · | $4.17B | $6.09B | $9.52B | $3.04B | · | |
| P/E | -9.8 | -8.5 | -1.2 | -0.2 | -54.9 | -73.4 | · | · | · | |
| P/S | 874.9 | 108.8 | 54.5 | · | · | · | · | · | · | |
| P/B | 3.6 | 1.9 | 0.9 | · | 24.1 | 42.3 | 67.4 | 20.9 | · | |
| P / Tangible Book | 3.6 | 1.9 | 0.9 | · | · | 42.3 | · | · | · | |
| P / Cash Flow | -13.8 | -8.7 | -4.2 | · | -70.0 | -95.1 | -166.8 | -72.5 | · | |
| P / FCF | · | · | · | · | -68.6 | -94.5 | -158.3 | -61.3 | · | |
| Earnings Yield | -10.2% | -11.7% | -81.2% | -508.9% | -1.8% | -1.4% | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $284.0K | $396.0K | $193.0K | $1M | $1M | $2M | $2M | $874.0K | $457.0K | $924.0K | · | · | · | $1M | |
| R&D Expense | $49M | $35M | $60M | $32M | $26M | $27M | $26M | $26M | $18M | $13M | $9M | $8M | $10M | $6M | $-6M | $7M | |
| SG&A Expense | $14M | $12M | $10M | $8M | $9M | $7M | $7M | $7M | $6M | $6M | $5M | $9M | $2M | $2M | $-9M | $2M | |
| Operating Expenses | $62M | $47M | $70M | $41M | $35M | $34M | $33M | $32M | $24M | $19M | $13M | $17M | $13M | $8M | $-15M | $9M | |
| Operating Income | $-61M | $-47M | $-70M | $-40M | $-35M | $-33M | $-32M | $-30M | $-22M | $-18M | $-13M | $-16M | $-12M | $-8M | $20M | $-8M | |
| Interest Income | $12M | $6M | $11M | $1M | $3M | $4M | $7M | $2M | $4M | $4M | · | · | · | · | · | · | |
| Other Non-op | $-370.0K | $-249.0K | $-409.0K | $-360.0K | $-107.0K | $-98.0K | $-382.0K | $22.0K | $-80.0K | $-114.0K | $-19.0K | $-15.0K | $-23.0K | $-3.0K | $-43.0K | $-2.0K | |
| Net Income | $-50M | $-41M | $-64M | $-37M | $-32M | $-30M | $-28M | $-25M | $-18M | $-14M | $-11M | $-15M | $-11M | $-7M | $-10M | $-8M | |
| EPS (Basic) | $-0.90 | $-0.85 | $-1.53 | $-0.97 | $-0.88 | $-0.82 | $-0.76 | $-0.74 | $-0.51 | $-0.54 | $16.16 | $-3.78 | $-12.73 | $-8.10 | $-22.99 | $-8.90 | |
| EPS (Diluted) | $-0.90 | $-0.85 | $-1.53 | $-0.97 | $-0.88 | $-0.82 | $-0.76 | $-0.74 | $-0.51 | $-0.54 | $16.16 | $-3.78 | $-12.73 | $-8.10 | $-22.99 | $-8.90 | |
| Shares (Basic) | 56,029,124 | 48,032,742 | · | 37,794,088 | 35,822,308 | 35,790,700 | · | 34,236,728 | 34,227,038 | 25,665,475 | · | 3,906,886 | 874,900 | 874,709 | · | 874,327 | |
| Shares (Diluted) | 56,029,124 | 48,032,742 | · | 37,794,088 | 35,822,308 | 35,790,700 | · | 34,236,728 | 34,227,038 | 25,665,475 | · | 3,906,886 | 874,900 | 874,709 | · | 874,327 | |
| EBITDA | $-61M | $-47M | · | $-40M | $-35M | $-33M | · | $-30M | $-22M | $-18M | · | $-16M | $-7M | $-32M | · | $-17M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $628M | $51M | $56M | $13M | $10M | $23M | $34M | $314M | $330M | $132M | $157M | $63M | $49M | $15M | $59M | |
| Short-term Investments | $776M | $484M | $353M | $347M | $244M | $253M | $252M | $247M | $47M | $47M | $41M | $33M | · | · | $60M | $69M | |
| Receivables | $106.0K | $1M | $52.0K | $5M | $39.0K | $1M | $0 | $1M | $840.0K | $435.0K | $294.0K | $232.0K | · | · | $5M | · | |
| Prepaid Expense | $11M | $7M | $5M | $6M | $6M | $7M | $5M | $4M | $3M | $3M | $3M | $832.0K | $1M | $3M | $905.0K | $4M | |
| Other Current Assets | $184.0K | $83.0K | $86.0K | $73.0K | $111.0K | $392.0K | $355.0K | · | · | · | $0 | · | · | · | · | · | |
| Current Assets | $898M | $1.12B | $409M | $414M | $264M | $271M | $281M | $287M | $366M | $381M | $177M | $191M | $79M | $83M | $82M | $132M | |
| PP&E (Net) | $418.0K | $274.0K | $296.0K | $185.0K | $207.0K | $191.0K | $194.0K | $189.0K | $189.0K | $195.0K | $185.0K | $195.0K | $0 | $0 | $142.0K | $6M | |
| PP&E (Gross) | $791.0K | $610.0K | $600.0K | $462.0K | $457.0K | $411.0K | $387.0K | $356.0K | $331.0K | $314.0K | $282.0K | $272.0K | · | · | $172.0K | · | |
| Accum. Depreciation | $373.0K | $336.0K | $304.0K | $277.0K | $250.0K | $220.0K | $193.0K | $167.0K | $142.0K | $119.0K | $97.0K | $77.0K | · | · | $30.0K | · | |
| Total Assets | $1.21B | $1.25B | $531M | $577M | $326M | $349M | $374M | $354M | $369M | $382M | $179M | $192M | $79M | $83M | $83M | $164M | |
| Accounts Payable | $6M | $5M | $10M | $7M | $5M | $8M | $5M | $8M | $4M | $3M | $3M | $1M | $813.0K | $1M | $1M | $3M | |
| Accrued Liabilities | $26M | $31M | $19M | $16M | $14M | $8M | $13M | $8M | $6M | $6M | $7M | $11M | · | · | $7M | $7M | |
| Current Liabilities | $34M | $38M | $31M | $24M | $20M | $17M | $18M | $16M | $10M | $9M | $10M | $13M | $4M | $6M | $8M | $13M | |
| Capital Leases | $913.0K | $965.0K | $1M | $1M | $1M | $1M | $1M | $0 | $30.0K | $97.0K | $168.0K | $257.0K | $0 | $0 | $438.0K | $27M | |
| Total Liabilities | $41M | $46M | $38M | $31M | $23M | $20M | $22M | $16M | $11M | $10M | $11M | $14M | $4M | $6M | $9M | $40M | |
| Common Stock | $55.0K | $54.0K | $43.0K | $43.0K | $32.0K | $32.0K | $31.0K | $29.0K | $29.0K | $29.0K | $15.0K | $15.0K | $61.0K | $61.0K | $0 | $61.0K | |
| Retained Earnings | $-428M | $-378M | $-337M | $-272M | $-236M | $-204M | $-174M | $-146M | $-121M | $-103M | $-89M | $-79M | $-434M | $-431M | $-46M | $-382M | |
| AOCI | $-2M | $-575.0K | $489.0K | $163.0K | $98.0K | $270.0K | $106.0K | $681.0K | $-37.0K | $-27.0K | $47.0K | $-4.0K | $-3.0K | $-16.0K | $-161.0K | $-462.0K | |
| Stockholders' Equity | $1.17B | $1.20B | $493M | $546M | $303M | $329M | $352M | $338M | $358M | $373M | $169M | $178M | $75M | $77M | $-44M | $124M | |
| Liabilities + Equity | $1.21B | $1.25B | $531M | $577M | $326M | $349M | $374M | $354M | $369M | $382M | $179M | $192M | $79M | $83M | $83M | $164M | |
| Shares Outstanding | 54,798,338 | 54,582,749 | 43,223,090 | 42,854,563 | 32,176,482 | 32,125,933 | 31,115,341 | 29,366,352 | 29,352,140 | 29,348,626 | 14,817,696 | 14,817,762 | 60,652,197 | 60,648,821 | 875,279 | 60,555,520 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $421.0K | · | $471.0K | |
| Stock-based Comp | $12M | $11M | $6M | $6M | $6M | $5M | $4M | $4M | $3M | $2M | $726.0K | $1M | $489.0K | $533.0K | $513.0K | $-3M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $18M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-49M | $-29M | $-47M | $-31M | $-24M | $-28M | $-27M | $-21M | $-15M | $-15M | $-12M | $17M | $21M | $-10M | $-9M | $16M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $245.0K | · | $158.0K | |
| Investing Cash Flow | $-479M | $-134M | $37M | $-201M | $26M | $15M | $-23M | $-259M | $1M | $-6M | $-8M | $-17M | $13M | $18M | $-13M | $-7M | |
| Stock Issued | $0 | $120.0K | $1.0K | $187.0K | $0 | $129.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $120.0K | · | · | · | $129.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $10M | $739M | $5M | $275M | $568.0K | $161.0K | $40M | $296.0K | $-2M | $218M | $-5M | $138M | $0 | $0 | $0 | $97M | |
| Net Change in Cash | $-517M | $577M | $-5M | $43M | $3M | $-13M | $-11M | $-280M | $-16M | $197M | $-25M | $139M | $34M | $8M | $-22M | $106M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-36M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -10173.7% | -18096.9% | -2852.7% | · | · | · | · | · | -1705.5% | · | · | · | · | |
| Net Margin | · | · | · | -9284.1% | -16388.1% | -2537.5% | · | · | · | · | · | -1597.7% | · | · | · | · | |
| EBITDA Margin | · | · | · | -10173.7% | -18096.9% | -2852.7% | · | · | · | · | · | -1705.5% | · | · | · | · | |
| ROA | -6.5% | -5.1% | · | -7.9% | -9.1% | -8.1% | · | -9.2% | -7.9% | -5.9% | · | -8.3% | -2.6% | -21.0% | · | -8.7% | |
| ROE | -6.8% | -5.3% | · | -8.3% | -9.6% | -8.4% | · | -9.8% | -8.1% | -6.1% | · | -9.8% | -3.1% | -25.5% | · | -10.2% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.1 | 29.3 | · | 17.3 | 13.1 | 16.0 | · | 18.3 | 36.5 | 42.5 | · | 14.6 | 19.5 | 13.9 | · | 10.2 | |
| Quick Ratio | 25.8 | 29.1 | · | 17.1 | 12.8 | 15.6 | · | 18.0 | 36.1 | 42.1 | · | 14.5 | 15.5 | 8.1 | · | 9.9 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | 0.1 | 0.4 | 1.6 | · | · | · | · | · | 8.0 | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.39 | $22.01 | · | $12.75 | $9.42 | $10.23 | · | $11.51 | $12.20 | $12.70 | · | $12.04 | $1.23 | $1.28 | · | $2.05 | |
| Revenue / Share | · | · | · | $0.01 | $0.01 | $0.03 | · | · | · | · | · | $0.24 | · | · | · | · | |
| Cash Flow / Share | · | $-0.60 | · | · | · | $-0.77 | · | · | · | $-0.58 | · | · | · | $-0.59 | · | · | |
| Cash / Share | $2.02 | $11.50 | · | $1.31 | $0.41 | $0.31 | · | $1.15 | $10.70 | $11.23 | · | $10.61 | $1.03 | $0.80 | · | $0.97 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | |
| EPS (TTM) | $-4.25 | $-4.23 | · | $-3.43 | $-3.20 | $-2.83 | · | $14.37 | $11.33 | $-0.89 | · | $-47.60 | $-52.72 | $-40.28 | · | $-9.89 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $3M | $5M | $7M | · | $5M | $4M | · | · | · | · | · | · | · | |
| Net Income TTM | $-192M | $-174M | · | $-126M | $-115M | $-101M | · | $-67M | $-57M | $-50M | · | $-43M | $-36M | $-31M | · | $-38M | |
| Market Cap | $5.34B | $4.58B | · | $1.69B | $599M | $583M | · | $804M | $760M | $880M | · | $203M | $738M | $767M | · | $1.37B | |
| P/E | -22.9 | -19.8 | · | -11.5 | -5.8 | -6.4 | · | 1.9 | 2.3 | -33.7 | · | -0.3 | -0.2 | -0.3 | · | -2.3 | |
| P/S | 2623.6 | 2249.8 | · | 547.9 | 123.5 | 89.3 | · | 149.8 | 184.5 | · | · | · | · | · | · | · | |
| P/B | 4.6 | 3.8 | · | 3.1 | 2.0 | 1.8 | · | 2.4 | 2.1 | 2.4 | · | 1.1 | 9.9 | 9.9 | · | 11.0 | |
| P / Tangible Book | 4.6 | 3.8 | · | 3.1 | 2.0 | 1.8 | · | 2.4 | 2.1 | 2.4 | · | 1.1 | 9.9 | 9.9 | · | 11.0 | |
| P / Cash Flow | · | -158.7 | · | · | · | -21.1 | · | · | · | -58.9 | · | · | · | -21.5 | · | · | |
| Earnings Yield | -4.4% | -5.0% | · | -8.7% | -17.2% | -15.6% | · | 52.5% | 43.8% | -3.0% | · | -348.2% | -433.5% | -318.7% | · | -43.8% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $2M | $6M | $3M | · | · |
| Margine Operativo % | -8739.3% | -1633.7% | · | · | · |
| Utile netto | $-162M | $-85M | $-44M | $-28M | $-71M |
| EPS Diluito | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 13.3 | 15.2 | 18.4 | · | 16.6 |
| Quick Ratio | 13.2 | 15.0 | 18.1 | · | 16.3 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | · | · | · | $-61M |
Proprietari istituzionali (13F) 284 filer · $5.9B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
284
Valore detenuto
$5.9B
Nuove posizioni
61
Posizioni chiuse
31
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 61 (-43 vs trimestre precedente) | 31 (+14 vs trimestre precedente) | 121 (+38 vs trimestre precedente) | 67 (+14 vs trimestre precedente) | +4.7M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FMR LLC | $799.325.570 | 8.199.893 | 13,66% | Azioni |
| BlackRock, Inc. | $401.990.169 | 4.123.822 | 6,87% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $314.848.897 | 3.229.882 | 5,38% | Azioni |
| Fairmount Funds Management LLC | $247.325.379 | 2.537.191 | 4,23% | Azioni |
| STATE STREET CORP | $229.798.634 | 2.357.440 | 3,93% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $210.514.689 | 2.159.568 | 3,60% | Azioni |
| Avidity Partners Management LP | $205.115.856 | 2.104.184 | 3,50% | Azioni |
| Octagon Capital Advisors LP | $179.525.699 | 1.841.667 | 3,07% | Azioni |
| TCG Crossover Management, LLC | $163.437.308 | 1.676.624 | 2,79% | Azioni |
| FRED ALGER MANAGEMENT, LLC | $126.967.018 | 1.302.493 | 2,17% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $122.696.604 | 1.258.502 | 2,10% | Azioni |
| Venrock Adviser, LLC | $115.026.400 | 1.180.000 | 1,97% | Azioni |
| UBS Group AG | $111.152.545 | 1.140.260 | 1,90% | Azioni |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $109.695.511 | 1.125.313 | 1,87% | Azioni |
| JENNISON ASSOCIATES LLC | $99.601.453 | 1.021.763 | 1,70% | Azioni |
| Polar Capital Holdings Plc | $99.305.410 | 1.018.726 | 1,70% | Azioni |
| CITADEL ADVISORS LLC | $95.034.324 | 974.911 | 1,62% | Azioni |
| FRANKLIN RESOURCES INC | $94.456.440 | 968.983 | 1,61% | Azioni |
| VANGUARD GROUP INC | $84.416.707 | 2.048.452 | 1,44% | Azioni |
| BAKER BROS. ADVISORS LP | $83.068.947 | 852.164 | 1,42% | Azioni |
| Logos Global Management LP | $77.984.000 | 800.000 | 1,33% | Azioni |
| Cormorant Asset Management, LP | $73.110.000 | 750.000 | 1,25% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $70.001.868 | 834.150 | 1,20% | Azioni |
| BRAIDWELL LP | $57.957.904 | 594.562 | 0,99% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $55.574.810 | 570.115 | 0,95% | Azioni |
| AMERIPRISE FINANCIAL INC | $51.859.546 | 531.999 | 0,89% | Azioni |
| Woodline Partners LP | $48.793.419 | 500.548 | 0,83% | Azioni |
| BARCLAYS PLC | $42.087.284 | 431.753 | 0,72% | Azioni |
| MPM BIOIMPACT LLC | $40.941.795 | 420.002 | 0,70% | Azioni |
| NORTHERN TRUST CORP | $40.141.386 | 411.791 | 0,69% | Azioni |
| Affinity Asset Advisors, LLC | $38.992.000 | 400.000 | 0,67% | Azioni |
| SILVERARC CAPITAL MANAGEMENT, LLC | $38.017.200 | 390.000 | 0,65% | Azioni |
| GOLDMAN SACHS GROUP INC | $37.253.054 | 382.161 | 0,64% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $35.674.073 | 365.963 | 0,61% | Azioni |
| Bain Capital Life Sciences Investors, LLC | $35.333.576 | 362.470 | 0,60% | Azioni |
| Spruce Street Capital LP | $34.587.464 | 354.816 | 0,59% | Azioni |
| Vivo Capital, LLC | $34.507.725 | 353.998 | 0,59% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $31.334.301 | 321.503 | 0,54% | Azioni |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $30.697.817 | 314.914 | 0,52% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $29.485.945 | 302.482 | 0,50% | Azioni |
| Driehaus Capital Management LLC | $28.782.530 | 295.266 | 0,49% | Azioni |
| First Turn Management, LLC | $27.856.957 | 285.771 | 0,48% | Azioni |
| Assenagon Asset Management S.A. | $27.357.665 | 280.649 | 0,47% | Azioni |
| TANG CAPITAL MANAGEMENT LLC | $25.802.176 | 264.692 | 0,44% | Azioni |
| Artisan Partners Limited Partnership | $25.176.062 | 258.269 | 0,43% | Azioni |
| BANK OF AMERICA CORP /DE/ | $25.036.081 | 256.833 | 0,43% | Azioni |
| Bank of New York Mellon Corp | $24.993.153 | 256.393 | 0,43% | Azioni |
| RTW INVESTMENTS, LP | $24.181.181 | 248.063 | 0,41% | Azioni |
| EMERALD ADVISERS, LLC | $24.156.031 | 247.805 | 0,41% | Azioni |
| Pictet Asset Management Holding SA | $24.106.317 | 247.295 | 0,41% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Evan Harwin, Tomas Kiselak ×5 depositi | 25 Novembre 2025 | 4,90% | Modifica | · | SEC |
| Avidity Partners Management LP, Avidity Partners Management (GP) LLC, Avidity Capital Partners Fund (GP) LP, Avidity Capital Partners (GP) LLC, Avidity Private Master Fund I LP, Michael Gregory ×4 depositi | 19 Novembre 2025 | 4,90% | Modifica | Investimento passivo | SEC |
| Viridian, LLC ×2 depositi | 12 Settembre 2024 | · | Deposito iniziale | · | SEC |
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×4 depositi | 15 Settembre 2023 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 36 insider · 13 dirigenti · 17 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Marino Garcia | CEO AND PRESIDENT | 07 Agosto 2026 M | 65.292 | 0 | 12 | $-27.961.831 |
| Ryan Savitz | EVP, CFO & CBO | 09 Luglio 2026 M | 0 | 0 | 13 | $-14.292.190 |
| Edward Carr | CHIEF ACCOUNTING OFFICER | 17 Settembre 2026 M | 0 | 0 | 10 | $-5.587.140 |
| Simrat Randhawa | EVP, Head of R&D | 01 Settembre 2026 M | 4.000 | 0 | 11 | $-15.001.124 |
| Adam M Veness | SVP, General Counsel and Sec. | 13 Agosto 2026 M | 15.000 | 0 | 5 | $-4.632.790 |
| David Wayne Nichols | Chief Technical Officer | 01 Agosto 2022 A | 14.306 | 0 | 0 | $0 |
| Lisa Olson | Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney | 01 Agosto 2022 A | 14.264 | 0 | 0 | $0 |
| Jeffrey Humphrey | Chief Medical Officer | 01 Agosto 2022 A | · | 0 | 0 | $0 |
| John C. Davis JR | Title: Head of Research and Development and Chief Medical Officer | 11 Febbraio 2021 A | 8.304 | 0 | 0 | $0 |
| Zoran Zdraveski | Title: Secretary and Chief Legal and Technology Operations Officer | 11 Febbraio 2021 A | 133.010 | 0 | 0 | $0 |
| Christina K. Isacson | Chief Business Officer | 10 Febbraio 2020 A | 83.786 | 0 | 0 | $0 |
| Jason Ryan | Title: Chief Operating and Financial Officer | 10 Febbraio 2020 A | · | 0 | 0 | $0 |
| COOKE MICHAEL P. | Chief Scientific Officer | 02 Dicembre 2019 S | 240.523 | 0 | 0 | $0 |
| Simon Read | Direttore | 19 Agosto 2026 M | 0 | 0 | 7 | $-630.786 |
| Anne Mcgeorge | Direttore | 10 Agosto 2026 M | 0 | 0 | 5 | $-844.822 |
| Jonathan Violin | Direttore | 21 Maggio 2026 A | · | 0 | 0 | $0 |
| Paula Soteropoulos | Direttore | 21 Maggio 2026 A | 0 | 0 | 3 | $-2.252.895 |
| Steven J. Romano | Direttore | 21 Maggio 2026 A | · | 0 | 0 | $0 |
| Alison Frances Lawton | Direttore | 21 Maggio 2026 A | · | 0 | 0 | $0 |
| MOULDER LEON O JR | Direttore | 23 Maggio 2024 A | 1.436.745 | 0 | 0 | $0 |
| Michael Vasconcelles | Direttore | 15 Agosto 2022 A | · | 0 | 0 | $0 |
| David Scadden | Direttore | 28 Giugno 2022 A | 228.175 | 0 | 0 | $0 |
| Jeffrey W. Albers | Direttore | 28 Giugno 2022 A | 4.152 | 0 | 0 | $0 |
| Thomas O Daniel | Direttore | 28 Giugno 2022 A | 101.926 | 0 | 0 | $0 |
| Bruce Booth | Direttore | 28 Giugno 2022 A | 1.250.000 | 0 | 0 | $0 |
| Amy L Ronneberg | Direttore | 28 Giugno 2022 A | 593.611 | 0 | 0 | $0 |
| Alexis Borisy | Direttore | 26 Agosto 2021 J | 4.100 | 0 | 0 | $0 |
| Michael W Bonney | Direttore | 01 Giugno 2021 A | 215.346 | 0 | 0 | $0 |
| Blake Byers | Direttore | 05 Giugno 2020 A | 3.339.137 | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | Proprietario del 10% | 11 Febbraio 2021 J | 3.148.399 | 0 | 0 | $0 |
| Sujay Kango | · | 21 Maggio 2026 A | · | 0 | 0 | $0 |
| Caren Deardorf | · | 30 Novembre 2022 A | 19.762 | 0 | 0 | $0 |
| Kristen Stants | · | 30 Novembre 2022 A | 20.264 | 0 | 0 | $0 |
| Stephen F. Mahoney | · | 30 Novembre 2022 A | 17.264 | 0 | 0 | $0 |
| Thomas W. Beetham | · | 30 Novembre 2022 A | 19.897 | 0 | 0 | $0 |
| Jason Gardner | · | 30 Novembre 2022 A | 292.872 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 37 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IBRN · iShares Trust | 5,04% | 3.652 SH | 11 Settembre 2026 | Giornaliero |
| PTH · Invesco Exchange-Traded Fund Trust | 1,90% | 62.115 SH | 02 Ottobre 2026 | Giornaliero |
| LABU · Direxion Shares ETF Trust | 0,96% | 44.156 NS | 31 Luglio 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,87% | 3.787 NS | 31 Luglio 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,53% | 24.335 SH | 02 Ottobre 2026 | Giornaliero |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,44% | 52.995 NS | 31 Luglio 2026 | N-PORT |
| IWO · iShares Trust | 0,32% | 444.336 SH | 11 Settembre 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,27% | 50.626 SH | 19 Agosto 2026 | Giornaliero |
| PWS · Pacer Funds Trust | 0,27% | 603 NS | 31 Luglio 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,18% | 1.463 NS | 31 Luglio 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,17% | 23.108 NS | 31 Luglio 2026 | N-PORT |
| RSSL · Global X Funds | 0,16% | 22.655 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,16% | 1.209.461 SH | 11 Settembre 2026 | Giornaliero |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 10.325 NS | 31 Luglio 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,15% | 29.943 SH | 19 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,14% | 272.370 SH | 19 Agosto 2026 | Giornaliero |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,14% | 17.898 NS | 31 Luglio 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,09% | 4.800 NS | 31 Luglio 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 16.364 SH | 11 Settembre 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 17.465 NS | 31 Luglio 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,05% | 110.607 SH | 19 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,05% | 71.218 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 457.520 SH | 19 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 10.691 SH | 02 Ottobre 2026 | Giornaliero |
| WSML · iShares Trust | 0,03% | 2.149 SH | 11 Settembre 2026 | Giornaliero |
| DCOR · Dimensional ETF Trust | 0,01% | 3.958 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1.650.280 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3.889 SH | 19 Agosto 2026 | Giornaliero |
| IWV · iShares Trust | 0,01% | 12.690 SH | 11 Settembre 2026 | Giornaliero |
| DFAU · Dimensional ETF Trust | 0,01% | 7.297 NS | 31 Luglio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 27.975 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 54.499 SH | 11 Settembre 2026 | Giornaliero |
| TILT · FlexShares Trust | 0,00% | 810 NS | 31 Luglio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 4.404 NS | 31 Luglio 2026 | N-PORT |
| ISCB · iShares Trust | · | 1.709 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 8.427 SH | 11 Settembre 2026 | Giornaliero |
| SMMV · iShares Trust | · | 2.457 SH | 19 Agosto 2026 | Giornaliero |
DNTH Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 22 analisti
COMPRA
Target mediano
$134.00
+52,2%
10 45,5%
Acquisto forte
11 50,0%
Compra
1 4,5%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
15 analisti · 2026-10-03Target medio $140.80 +59,9%
← Sotto tutti i target
Prezzo attuale $88.04
Basso$122.00
Media$140.80
Alto$200.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| VKTX | $4.04B | -11.0 | · | · | -47.3% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 4, 2026